Stock ANNX BTA ANNEXIN PHARMACEUTICALS AB (PUBL)
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm

Equities

ANNX BTA

SE0013748894

Delayed Nasdaq Stockholm
Other stock markets
 		5-day change 1st Jan Change
- SEK -.--% Intraday chart for Annexin Pharmaceuticals AB (publ) -3.17% -.--%
23/05 Annexin Pharmaceuticals AB Elects Mikael Lönn as New Ordinary Member of the Board of Directors CI
30/04 Annexin Pharmaceuticals AB Announces Phase II Study Fully Recruited with Positive Signals CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Annexin Pharmaceuticals AB Elects Mikael Lönn as New Ordinary Member of the Board of Directors
CI
Annexin Pharmaceuticals Names New Finance Chief
MT
Annexin Pharmaceuticals AB Appoints Susanne Andersson as CFO
CI
Annexin Pharmaceuticals AB Appoints Dr. Alain Thibault as Therapeutic Area Head of Oncology
CI
Annexin Pharmaceuticals AB Appoints Mario Fsadni as Head of Ophthalmology
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANNX Stock
  4. ANNX BTA Stock
  5. News Annexin Pharmaceuticals AB (publ)
  6. Insiders